The pharma commercialization services sector is benefiting from a powerful set of structural tailwinds—including a replenished drug development pipeline, growing complexity of novel modalities, and greater adoption of AI-driven commercialization tools—all of which are creating robust and sustained demand for third-party commercialization expertise. 

Outsourced Pharma Services: Deerfield and the Rising Demand for Commercialization

HCLS Article Deerfield Header

Harris-Williams Bio-Crop 0009 0181 CheairsPorter

Group Head, Managing Director

Profile

Harris-Williams Bio-Crop 0074 1198 GeoffSmith

Harris-Williams Bio-Crop 0106 0433 TylerBradshaw

Managing Director

Harris-Williams Bio-Crop 0021 089 DanLinsalata

bio-crop 0000 0855 RobCrampton

Director

HCLS Article Deerfield Web Media

Fueled by pharma’s recovery and an influx of complex drug launches, demand for third-party commercialization services will see sustained growth.

Outsourced Pharma Services: Deerfield and the Demand for Commercialization

The Deerfield Group Receives a Majority Investment from Martis Capital

6743 Deerfield Agency NT

Mergers & Acquisitions

SSI Strategy Acquired by Clinigen Group

6749 SSI Strategy NT

TPG Growth Completes Continuation Vehicle for AnovoRx

6829 PCA AvonoRx NT

Mercalis Merges With PharmaCord

6381 Mercalis NT

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Pharmalex

Germany

5543 Pharmalex (Project I) NT

Celerion

United States

5516 Celerion NT

Harris Williams advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners. Jordi Labs is a leader in analytical chemistry testing, delivering a full suite of regulatory, investigative, and related services to the medical device, pharmaceutical, and other industries.

Jordi Labs

5663 Jordi Labs NT

The CM Group

5679 The CM Group

Security and Fraud Awareness

Site Map

Privacy Policy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Select Activity

Outsourced Pharma Services: SSI Strategy Combines Science and Consulting Expertise

The Convergence of Pharmacy and Pharma Services: Hub Services Show Opportunity

Select Activity

Related Insights

Outsourced Pharma Services: SSI Strategy Combines Science and Consulting Expertise

The Convergence of Pharmacy and Pharma Services: Hub Services Show Opportunity